Company profile for GSK

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At GSK we have a challenging mission: to improve the quality of human life by enabling people to do more, feel better, live longer. Find out how this shapes everything we do, including our R&D, our partnerships, our work with communities and our efforts to prevent and treat disease around the world. We are a science-led global healthcare company with a mission: we want to help people to do more, feel better, live longer. The...
At GSK we have a challenging mission: to improve the quality of human life by enabling people to do more, feel better, live longer. Find out how this shapes everything we do, including our R&D, our partnerships, our work with communities and our efforts to prevent and treat disease around the world. We are a science-led global healthcare company with a mission: we want to help people to do more, feel better, live longer. The vaccines, medicines and consumer healthcare products that we research and develop can improve people’s health and well-being, ultimately helping them to live life to its fullest and contribute.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
980 Great West Road, Brentford, Middlesex TW8 9GS England
Telephone
Telephone
+44 (0)20 8047 5000
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

CPhI China

Not Confirmed

envelop Contact Supplier

CPhI China

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

INTERVIEW #SpeakPharma

[Sponsored by another company]
Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets
With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experience Addressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise.HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

Impressions: 569

https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets

Radio Compass
06 May 2025

VLOG #PharmaReel

[Sponsored by another company]
This PharmaReel highlights Transo-Pharm USA’s offerings of premium Phyto Cannabidiol (CBD) and Phyto Cannabigerol (CBG) isolates from its cGMP-certified facility inspected by the FDA and ANVISA. The company has an expanded reach across the US and EU.

Impressions: 656

read-more

DATA COMPILATION #PharmaFlow

[Sponsored by another company]
US drug shortages reduce 16% YoY in Q1 2025; CNS drugs, antimicrobials face highest scarcities
The pharmaceutical industry in the United States continued to grapple with drug shortages during the first quarter (Q1) of 2025. According to the American Society of Health‑System Pharmacists (ASHP), the total number of active shortages stood at 270 as of March 31, 2025 — only slightly below the 277 reported in September 2024, but down 16.4 percent from an all‑time high of 323 reported in Q1 2024.These numbers imply that while dramatic surges in drug shortages may have subsided, underlying vulnerabilities in manufacturing, supply chains, and raw‑material sourcing continue to frustrate efforts towards a durable resolution.A deeper analysis of these drug scarcities reveals that 41 percent of the 270 active shortages first emerged in 2022 or earlier. This implies that many of the current disruptions have become chronic in nature and are exerting pressure on pharmacy operations. View Our Interactive Dashboard on Drug Shortages So Far in 2025 (Free Excel Available)CNS drugs dominate with 49 meds in short supply; antimicrobials face shortage of 39 drugsClass‑specific analysis reveals that central nervous system (CNS) agents remained the most disrupted category, with 49 distinct CNS drugs having faced scarcities during Q1. This group spans anxiolytics (anti-anxiety drugs) such as clonazepam and flurazepam, sedatives like lorazepam and midazolam, and stimulants such as methylphenidate and lisdexamfetamine. These shortages pose two challenges — controlling seizures and managing sedation in acute care settings. After CNS agents, antimicrobials was the second‑largest category, with shortages affecting 39 drugs. Key antibacterial and anti-fungal agents such as cefotaxime sodium powder for injection, clindamycin phosphate, rifampin, and metronidazole find themselves on ASHP’s active‑shortage roster, threatening both routine hospital protocols and emergency sepsis management.Fluids and electrolytes occupied the third spot, with 29 items facing shortage in Q1 2025. Hormone agents, including insulin analogs, ranked fourth with 24 drugs in short supply.Chemotherapy medications rounded out the top five categories, with 23 antineoplastic agents (a broad class of medications used to treat cancer) flagged as actively constrained in Q1 2025. Notable shortages included azacitidine, carboplatin, methotrexate, and streptozocin. View Our Interactive Dashboard on Drug Shortages So Far in 2025 (Free Excel Available) US faces 26 new shortages; Pharmacopeia list warns of 100 vulnerable medicationsThe first quarter saw the emergence of 26 new shortage declarations, emphasizing that even drugs previously deemed reliably sourced can fall into scarcity. The US has been facing a shortage of attention deficit hyperactivity disorder (ADHD) drugs since 2022. The new shortages included ADHD transdermal patch methylphenidate, peginterferon alfa‑2a (Pegasys) used in chronic hepatitis B and C, and bacitracin ophthalmic ointment.The fragility of the pharmaceutical supply chains has been particularly evident in the aftermath of natural disasters. Hurricane Helene’s flooding at Baxter’s Marion, North Carolina, facility deeply affected IV‑solution supply lines. Baxter supplies roughly 60 percent of the US’ IV fluids and the ASHP report listed “hurricane” as the reason behind nine percent of drug shortages, as of January 2025.Regulatory and policy interventions continue to evolve. The US Pharmacopeia’s inaugural Vulnerable Medicines List, launched in 2025, identifies 100 drugs at the highest risk of future shortages, with a particular focus on injectables (comprising 71 percent of the list) and essential hospital care.Antibiotics, medications for pain management and oncology are the other drugs on the list. Although 61 percent of these vulnerable medicines were not in active shortage at the time of listing, their inclusion is intended to galvanize manufacturers and purchasing organizations to bolster inventories.Meanwhile, the Government Accountability Office in the US has called on the Department of Health and Human Services (HHS) to establish a formal coordination mechanism, warning that elimination of the HHS supply‑chain coordinator role in May 2025 risks fragmenting federal response efforts. View Our Interactive Dashboard on Drug Shortages So Far in 2025 (Free Excel Available) Global shortages mirror US patterns; Europe launches monitoring platform Globally, we notice comparable trends. For instance, Europe has rolled out the European Shortages Monitoring Platform (ESMP) this year in order to centralize shortage reporting across member states. Critical‑medicine shortages in the EU — in areas such as oncology, ADHD, and critical care analgesics — mirror US patterns. The European Medicines Agency’s shortage list currently holds 37 human drugs.According to Health Canada’s May 12, 2025 update, its Tier 3 list had 18 drug shortages that are considered to have the greatest impact on Canada’s drug supply and health‑care system. Tier 3 designation is based on medical necessity and minimal availability of alternatives.In hematology and oncology, scarcity of essential drugs like Oncaspar for acute lymphoblastic leukemia, idarubicin and lomustine for leukemias and brain tumors, anagrelide for thrombocythemia, and preservative‑free methotrexate for various malignancies underscore the impact these drug shortages can have on treatment. View Our Interactive Dashboard on Drug Shortages So Far in 2025 (Free Excel Available) Our viewThe global pharma supply chain is dealing with a fresh wave of uncertainties, especially with the likelihood of tariffs on drugs imported into the US. Analysts warn that the proposed pharmaceutical tariffs could exacerbate supply issues.Over 50 percent of drugs used in the US are manufactured abroad. Generic sterile injectable drugs — like chemotherapy medications and IV saline — are particularly vulnerable due to their complex manufacturing processes and low profit margins. Generic drugs (which account for 90 percent of prescriptions filled in the US) could face increased pressure, as many rely on raw materials from China and India. This could result in more severe drug shortages in the future. 

Impressions: 433

https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities

#PharmaFlow by PHARMACOMPASS
22 May 2025

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercepharma.com/pharma/comeback-trial-gsks-blenrep-scores-thumbs-chmp

FIERCE PHARMA
24 May 2025

https://www.reuters.com/sustainability/boards-policy-regulation/gsks-asthma-drug-nucala-wins-fdas-approval-treat-smokers-lung-2025-05-22/

REUTERS
23 May 2025

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514

FDA
22 May 2025

https://www.gsk.com/en-gb/media/press-releases/gsk-to-acquire-efimosfermin-a-phase-iii-ready-potential-best-in-class-specialty-medicine-to-treat-and-prevent-progression-of-steatotic-liver-disease-sld/

PRESS RELEASE
15 May 2025

https://www.reuters.com/business/healthcare-pharmaceuticals/iteos-gsk-discontinue-lung-cancer-therapy-development-2025-05-13/

REUTERS
14 May 2025

https://www.indianpharmapost.com/news/glaxosmithkline-pharmaceuticals-posts-fy25-pat-at-rs-915-cr-17155

INDPHARMAPOST
14 May 2025

Excipients

Click here to find the perfect excipient manufacturers by their capabilities

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Sierra Oncology and get a quotation

Sierra Oncology is a supplier offers 142 products (APIs, Excipients or Intermediates).

Find a price of Cefuroxime Sodium bulk with DMF, CEP offered by Sierra Oncology

Find a price of Fluticasone Propionate bulk with DMF, CEP offered by Sierra Oncology

Find a price of Amoxicillin Trihydrate bulk with CEP offered by Sierra Oncology

Find a price of Betamethasone Valerate bulk with CEP offered by Sierra Oncology

Find a price of Ceftazidime bulk with CEP offered by Sierra Oncology

Find a price of Clavulanic Acid bulk with CEP offered by Sierra Oncology

Find a price of Clobetasol Propionate bulk with CEP offered by Sierra Oncology

Find a price of Salbutamol Sulphate bulk with CEP offered by Sierra Oncology

Find a price of Ceftazidime bulk with DMF offered by Sierra Oncology

Find a price of Cefuroxime Axetil bulk offered by Sierra Oncology

Find a price of Clavulanic Acid bulk offered by Sierra Oncology

Find a price of Fluticasone Furoate bulk with DMF offered by Sierra Oncology

Find a price of Fluticasone Propionate bulk with DMF offered by Sierra Oncology

Find a price of Griseofulvin bulk offered by Sierra Oncology

Find a price of Labetalol Hydrochloride bulk offered by Sierra Oncology

Find a price of Mupirocin Calcium bulk offered by Sierra Oncology

Find a price of Paroxetine Hydrochloride bulk with DMF offered by Sierra Oncology

Find a price of Salbutamol Sulphate bulk with DMF offered by Sierra Oncology

Find a price of Salmeterol Xinafoate bulk with DMF offered by Sierra Oncology

Find a price of Umeclidinium Bromide bulk with DMF offered by Sierra Oncology

Find a price of Vilanterol Trifenatate bulk with DMF offered by Sierra Oncology

Find a price of bulk with JDMF offered by Sierra Oncology

Find a price of 6-Aminopenicillanic Acid bulk offered by Sierra Oncology

Find a price of Albendazole bulk offered by Sierra Oncology

Find a price of Amoxicillin Sodium bulk offered by Sierra Oncology

Find a price of Amoxicillin Trihydrate bulk offered by Sierra Oncology

Find a price of Ampicillin bulk offered by Sierra Oncology

Find a price of Ampicillin Sodium bulk offered by Sierra Oncology

Find a price of Ampicillin Trihydrate bulk offered by Sierra Oncology

Find a price of Auranofin bulk offered by Sierra Oncology

Find a price of Beclomethasone Dipropionate bulk offered by Sierra Oncology

Find a price of Betamethasone Dipropionate bulk offered by Sierra Oncology

Find a price of Betamethasone Valerate bulk offered by Sierra Oncology

Find a price of Calcitonin bulk offered by Sierra Oncology

Find a price of Caramiphen Ethanedisulfonate bulk offered by Sierra Oncology

Find a price of Carbenicillin Indanyl bulk offered by Sierra Oncology

Find a price of Cephalexin bulk offered by Sierra Oncology

Find a price of Cephalosporin bulk offered by Sierra Oncology

Find a price of Cephradine bulk offered by Sierra Oncology

Find a price of Chlorpheniramine Maleate bulk offered by Sierra Oncology

Find a price of Cimetidine bulk offered by Sierra Oncology

Find a price of Clobetasol Propionate bulk offered by Sierra Oncology

Find a price of Clobetasone Butyrate bulk offered by Sierra Oncology

Find a price of Cloxacillin Benzathine bulk offered by Sierra Oncology

Find a price of Cloxacillin Sodium bulk offered by Sierra Oncology

Find a price of Deoxyuridine bulk offered by Sierra Oncology

Find a price of Diethylcarbamazine Citrate bulk offered by Sierra Oncology

Find a price of Diphenidol bulk offered by Sierra Oncology

Find a price of Diphenylpyraline bulk offered by Sierra Oncology

Find a price of Dopamine bulk offered by Sierra Oncology

Find a price of Doxepin Hydrochloride bulk offered by Sierra Oncology

Find a price of Fondaparinux Sodium bulk offered by Sierra Oncology

Find a price of Hydrochlorothiazide bulk offered by Sierra Oncology

Find a price of Isopropamide Iodide bulk offered by Sierra Oncology

Find a price of Liothyronine Sodium bulk offered by Sierra Oncology

Find a price of Megestrol Acetate bulk offered by Sierra Oncology

Find a price of Methicillin bulk offered by Sierra Oncology

Find a price of Mupirocin bulk offered by Sierra Oncology

Find a price of Nafcillin Sodium bulk offered by Sierra Oncology

Find a price of Oxacillin Sodium bulk offered by Sierra Oncology

Find a price of Paroxetine Hydrochloride bulk offered by Sierra Oncology

Find a price of Penicillin G Potassium bulk offered by Sierra Oncology

Find a price of Propyliodone bulk offered by Sierra Oncology

Find a price of Sodium Dicloxacillin bulk offered by Sierra Oncology

Find a price of Streptokinase bulk offered by Sierra Oncology

Find a price of Streptomycin bulk offered by Sierra Oncology

Find a price of Sucralfate bulk offered by Sierra Oncology

Find a price of Tetanus Immunoglobulin bulk offered by Sierra Oncology

Find a price of Ticarcillin bulk offered by Sierra Oncology

Find a price of Ticarcillin Monosodium bulk offered by Sierra Oncology

Find a price of Tranylcypromine Sulfate bulk offered by Sierra Oncology

Find a price of Trifluoperazine Hydrochloride bulk offered by Sierra Oncology

Find a price of Vitamin B12 bulk offered by Sierra Oncology

Find a price of Zidovudine bulk offered by Sierra Oncology

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL AND GENERAL OPERATING PROCEDURES IN SINGAPORE bulk offered by Sierra Oncology

Find a price of COMPOUND 904 bulk offered by Sierra Oncology

Find a price of BUILDINGS AND FACILITIES IN SEALS SANDS, ENGLAND bulk offered by Sierra Oncology

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN MONTROSE, ANGEES, SCOTLAND. bulk offered by Sierra Oncology

Find a price of MFG. SITE FACILITIES UTILIZED IN SPEKE LIVERPOOL (UK) bulk offered by Sierra Oncology

Find a price of FACILITIES&CONTROLS AT HARLOW AND GREAT BURGH RESEARCH SITES, ENGLAND bulk offered by Sierra Oncology

Find a price of FACIL, PERSONNEL AND GENERAL OPERATING PROCEDURES IN HARLOW, ESSEX. bulk offered by Sierra Oncology

Find a price of ENTRENOL bulk offered by Sierra Oncology

Find a price of FACILITIES & CONTROLS OF THE WELLCOME FOUNDATION IN KENT ENGLAND bulk offered by Sierra Oncology

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN CAROLINA, PUERTO RICO. bulk offered by Sierra Oncology

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN CIDRA, PUERTO RICO. bulk offered by Sierra Oncology

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES. bulk offered by Sierra Oncology

Find a price of MFGR, CONTROL PROCEDURES & FACILITIES-MYERSTOWN, PA., PLANT bulk offered by Sierra Oncology

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN CUERNAVACA, MEXICO. bulk offered by Sierra Oncology

Find a price of BRL 47539 (2-ACETOXYMETHYL-4-IODOBUT-1-YL-ACETATE) bulk offered by Sierra Oncology

Find a price of MANUFACTURING SITE, FACILITIES, PESONNEL, AND GENERAL OPERATING PROCEDURES IN WEST SUSSEX, ENGLAND. bulk offered by Sierra Oncology

Find a price of MANUFACTURING SITE AND FACILITIES FOR ANNAN, UK PLANT bulk offered by Sierra Oncology

Find a price of FACILITIES AND OPERATING PROCEDURES IN TIANJIN, CHINA bulk offered by Sierra Oncology

Find a price of MFG. FACILITIES LOCATED IN JURONG, SINGAPORE bulk offered by Sierra Oncology

Find a price of 7-ACA TOSYLATE bulk offered by Sierra Oncology

Find a price of PENN CHEMICALS PRODUCTION FACILITY IN COUNTY CORK, IRELAND bulk offered by Sierra Oncology

Find a price of FACILITIES AND MANUFACTURING bulk offered by Sierra Oncology

Find a price of GENERAL OPERATING PROCEDURES SINGAPORE PLANT bulk offered by Sierra Oncology

Find a price of FACIL, PERSONNEL & GENL OPER PROCED IN GREAT BURGH, EPSOM, U.K. bulk offered by Sierra Oncology

Find a price of CLENOLIXIMAB [CHIMERIC (MACAQUE/HUMAN) MONOCLONAL ANTIBODY (SB-217969) (CHO CELLS, SMITHKLINE BEECHAM) TO CD4] bulk offered by Sierra Oncology

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN TONBRIDGE, KENT, ENGLAND. bulk offered by Sierra Oncology

Find a price of L-DM1 bulk offered by Sierra Oncology

Find a price of ASO1B ADJUVANT SYSTEM bulk offered by Sierra Oncology

Find a price of MANUFACTURING FACILITY AT VERONA, ITALY. bulk offered by Sierra Oncology

Find a price of MANUFACTURING PRODUCTION FACILITY IN TORONTO, CANADA bulk offered by Sierra Oncology

Find a price of O/4 DIHYDROCHLORIDE DIHYRATE (CPZ ROUTE) bulk offered by Sierra Oncology

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN BOMBAY, INDIA. bulk offered by Sierra Oncology

Find a price of 0/4 DIHYDROCHLORIDE DIHYDRATE (CEPHALORIDINE ROUTE-CP)-ULVERSTON PLANT bulk offered by Sierra Oncology

Find a price of FACILITY IN BUCKHAVEN, UNITED KINGDOM bulk offered by Sierra Oncology

Find a price of FACILITIES UTILIZED IN WARE HERTS, UNITED KINGDOM bulk offered by Sierra Oncology

Find a price of FACILS AND GEN OPER PROCEDS AT THE ULVERSTON PLANT bulk offered by Sierra Oncology

Find a price of FACILITY LOCATED IN EDINBURG, SCOTLAND bulk offered by Sierra Oncology

Find a price of SYNTHESIS & QUALITY CONTROLS FOR 5,7-DICHLORO-8-HYDROXYQUINOLONE bulk offered by Sierra Oncology

Find a price of GENERAL OPERATING PROCEDURES FOR THE HEPPIGIES, BELGIUM--ANTIBIOTICS bulk offered by Sierra Oncology

Find a price of 'ZENTEL' 'TILTAB' TABLETS bulk offered by Sierra Oncology

Find a price of CHIMERIC (MACAQUE VARIABLE/HUMAN CONSTANT) (RECOMBINANT, CHO CELLS) MONOCLONAL ANTIBODY (SB 210396; CE9.1) TO HUMAN CD4 ANTIGEN bulk offered by Sierra Oncology

Find a price of HIV VACCINE (GPL 120/NEFTA/ASO2A) bulk offered by Sierra Oncology

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN GREENVILLE, NORTH CAROLINA. bulk offered by Sierra Oncology

Find a price of FACILITIES, METHODS AND CONTROLS bulk offered by Sierra Oncology

Find a price of Abacavir Sulfate bulk offered by Sierra Oncology

Find a price of Benzyl Penicillin bulk offered by Sierra Oncology

Find a price of Cabotegravir bulk offered by Sierra Oncology

Find a price of Cabotegravir Sodium bulk offered by Sierra Oncology

Find a price of CAS 103639-04-9 bulk offered by Sierra Oncology

Find a price of Daprodustat bulk offered by Sierra Oncology

Find a price of Dolutegravir Sodium bulk offered by Sierra Oncology

Find a price of Dutasteride bulk offered by Sierra Oncology

Find a price of Epsiprantel bulk offered by Sierra Oncology

Find a price of Fluticasone Furoate bulk offered by Sierra Oncology

Find a price of Lacidipine bulk offered by Sierra Oncology

Find a price of Lamivudine bulk offered by Sierra Oncology

Find a price of Nabumetone bulk offered by Sierra Oncology

Find a price of Naratriptan Hydrochloride bulk offered by Sierra Oncology

Find a price of Nelarabine bulk offered by Sierra Oncology

Find a price of Ondansetron bulk offered by Sierra Oncology

Find a price of Pazopanib Hydrochloride bulk offered by Sierra Oncology

Find a price of Ranitidine Hydrochloride bulk offered by Sierra Oncology

Find a price of Retapamulin bulk offered by Sierra Oncology

Find a price of Trametinib bulk offered by Sierra Oncology

Find a price of Umeclidinium Bromide bulk offered by Sierra Oncology

Find a price of Vilanterol Trifenatate bulk offered by Sierra Oncology

Find a price of Zanamivir bulk offered by Sierra Oncology

Find a price of MEDICATED FEED bulk offered by Sierra Oncology

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty